+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Atrial Fibrillation Market by Product, Device, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4858006
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Atrial Fibrillation Market grew from USD 9.46 billion in 2023 to USD 10.75 billion in 2024. It is expected to continue growing at a CAGR of 13.71%, reaching USD 23.28 billion by 2030.

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by irregular and often rapid heart rhythm that can lead to stroke, heart failure, and other cardiac complications. The increasing prevalence of cardiovascular diseases and geriatric populations are key drivers for the AF market's growth, as they enhance the demand for effective diagnosis and treatment solutions. The necessity for advanced AF management solutions stems from the need to mitigate associated risks and improve patient outcomes, with applications spanning pharmaceuticals, surgery, and non-invasive therapies. End-use sectors include hospitals, cardiac centers, and ambulatory surgical centers where advances in AF management are applied. Market insights reveal significant growth factors such as technological advancements in diagnostic devices, increased healthcare investments, and a rise in tele-health and remote monitoring systems. Moreover, potential opportunities exist in developing cost-effective, patient-centric solutions and enhancing electrocardiogram (ECG) monitoring technologies for early detection and management. However, limitations include the high cost of AF treatments and devices, stringent regulatory requirements, and a shortage of skilled electrophysiologists. Addressing these challenges necessitates streamlined regulatory pathways and improved training programs. Key areas for innovation include AI-based diagnostic tools, personalized medicine approaches, and minimally invasive surgical technologies designed to enhance treatment efficacy. The nature of the AF market is dynamic, with intense competition among key players striving to develop novel therapies and devices. To capitalize on market opportunities, companies should focus on R&D investments, strategic collaborations, and expanding their product portfolios to include cutting-edge AF management technologies. By emphasizing a patient-centric approach and harnessing technological advancements, businesses can effectively navigate the complexities of the AF market, catering to the evolving needs of healthcare providers and patients alike.

Understanding Market Dynamics in the Atrial Fibrillation Market

The Atrial Fibrillation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of atrial fibrillation in geriatric population
    • Government and global health organizations’ strategies to improve atrial fibrillation treatment
    • Increasing preference of catheter ablation for cardiac arrhythmia treatment
  • Market Restraints
    • High price of treatment and dearth of skilled professionals
  • Market Opportunities
    • Technology advancements in treatment and diagnostic methods to atrial fibrillation
    • Favorable approvals for atrial fibrillation drugs and treatment
  • Market Challenges
    • Incomplete understanding of the pathophysiology of AF

Exploring Porter’s Five Forces for the Atrial Fibrillation Market

Porter’s Five Forces framework further strengthens the insights of the Atrial Fibrillation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Atrial Fibrillation Market

External macro-environmental factors deeply influence the performance of the Atrial Fibrillation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Atrial Fibrillation Market

The Atrial Fibrillation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Atrial Fibrillation Market

The Atrial Fibrillation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Atrial Fibrillation Market

The Atrial Fibrillation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, AFreeze GmbH, AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Carima, Inc., CathRx Ltd, GE Healthcare, Japan Lifeline Co, Johnson & Johnson Services, Inc., Koninklijke Philips N.V, Medtronic PLC, Osypka AG, Siemens Healthcare GmbH, St. Jude Medical, Inc., and Vanguard AG.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Access Devices
    • Cardiac Monitors or Implantable Loop Recorder
    • EP Ablation Catheters
    • EP Diagnostic Catheter
    • Intracardiac Echocardiography
    • Left Atrial Appendage Closure Devices
    • Mapping & Recording Systems
  • Device
    • Non-Surgical Devices
      • Access Devices
      • Advanced Diagnostic Catheters
      • Cardiac Monitors
      • Conventional Diagnostic Catheters
        • Fixed Diagnostic Catheters
        • Steerable Diagnostic Catheters
      • Diagnostic Catheters
      • Electric Cardioversion
      • Intracardiac Echocardiography (ICE) Systems
      • Left Atrial Appendage & Closure Devices
      • Mapping & Recording Systems
    • Surgical Devices
      • Catheter Ablation
      • Cryoablation
      • Laser-Based Catheter Ablation
      • Maze Surgery
      • Microwave-Based Catheter Ablation
      • Navigational Advanced Mapping Accessories
      • Radiofrequency Catheter Ablation
        • Conventional RF Ablation Catheters
        • Irrigated-tip RF Ablation Catheters
  • End-User
    • Cardiology
    • Musculoskeletal
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of atrial fibrillation in geriatric population
5.1.1.2. Government and global health organizations’ strategies to improve atrial fibrillation treatment
5.1.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
5.1.2. Restraints
5.1.2.1. High price of treatment and dearth of skilled professionals
5.1.3. Opportunities
5.1.3.1. Technology advancements in treatment and diagnostic methods to atrial fibrillation
5.1.3.2. Favorable approvals for atrial fibrillation drugs and treatment
5.1.4. Challenges
5.1.4.1. Incomplete understanding of the pathophysiology of AF
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Atrial Fibrillation Market, by Product
6.1. Introduction
6.2. Access Devices
6.3. Cardiac Monitors or Implantable Loop Recorder
6.4. EP Ablation Catheters
6.5. EP Diagnostic Catheter
6.6. Intracardiac Echocardiography
6.7. Left Atrial Appendage Closure Devices
6.8. Mapping & Recording Systems
7. Atrial Fibrillation Market, by Device
7.1. Introduction
7.2. Non-Surgical Devices
7.2.1. Access Devices
7.2.2. Advanced Diagnostic Catheters
7.2.3. Cardiac Monitors
7.2.4. Conventional Diagnostic Catheters
7.2.4.1. Fixed Diagnostic Catheters
7.2.4.2. Steerable Diagnostic Catheters
7.2.5. Diagnostic Catheters
7.2.6. Electric Cardioversion
7.2.7. Intracardiac Echocardiography (ICE) Systems
7.2.8. Left Atrial Appendage & Closure Devices
7.2.9. Mapping & Recording Systems
7.3. Surgical Devices
7.3.1. Catheter Ablation
7.3.2. Cryoablation
7.3.3. Laser-Based Catheter Ablation
7.3.4. Maze Surgery
7.3.5. Microwave-Based Catheter Ablation
7.3.6. Navigational Advanced Mapping Accessories
7.3.7. Radiofrequency Catheter Ablation
7.3.7.1. Conventional RF Ablation Catheters
7.3.7.2. Irrigated-tip RF Ablation Catheters
8. Atrial Fibrillation Market, by End-User
8.1. Introduction
8.2. Cardiology
8.3. Musculoskeletal
9. Americas Atrial Fibrillation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Atrial Fibrillation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Atrial Fibrillation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ATRIAL FIBRILLATION MARKET RESEARCH PROCESS
FIGURE 2. ATRIAL FIBRILLATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ATRIAL FIBRILLATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ATRIAL FIBRILLATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ATRIAL FIBRILLATION MARKET DYNAMICS
TABLE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING & RECORDING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE & CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING & RECORDING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LASER-BASED CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE-BASED CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 71. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 72. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 106. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 107. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 108. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 109. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 113. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 114. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 115. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 116. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 117. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 127. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 128. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 129. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 130. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 131. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 169. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 170. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 171. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 172. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 173. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 189. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 198. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 199. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 200. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 201. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 202. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 205. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 206. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 207. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 208. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 209. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 212. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 216. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 220. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 223. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 233. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 234. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 235. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 236. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 237. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 254. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 255. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 256. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 257. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 258. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 261. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 262. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 263. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 264. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 265. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 268. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 269. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 270. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 271. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 272. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 296. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 297. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 298. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 299. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 300. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 316. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 317. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 318. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 319. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 320. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
TABLE 321. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES ATRIAL FIB

Companies Mentioned

The leading players in the Atrial Fibrillation market, which are profiled in this report, include:
  • Abbott Laboratories
  • Acesion Pharma ApS
  • AFreeze GmbH
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Carima, Inc.
  • CathRx Ltd
  • GE Healthcare
  • Japan Lifeline Co
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V
  • Medtronic PLC
  • Osypka AG
  • Siemens Healthcare GmbH
  • St. Jude Medical, Inc.
  • Vanguard AG

Methodology

Loading
LOADING...

Table Information